Ruthenium(11) metal complexes for photodynamic therapy (PDT) or as imaging agents

Erby, Marialuisa

dc.contributor.advisor	Williams, DC
dc.contributor.author	Erby, Marialuisa
dc.date.accessioned	2019-11-06T09:56:52Z
dc.date.available	2019-11-06T09:56:52Z
dc.date.issued	2013
dc.identifier.citation	Marialuisa Erby, 'Ruthenium(11) metal complexes for photodynamic therapy (PDT) or as imaging agents', [thesis], Trinity College (Dublin, Ireland). School of Biochemistry and Immunology, 2013, pp 314
dc.identifier.other	THESIS 10260
dc.identifier.uri	http://hdl.handle.net/2262/90127
dc.description.abstract	Photodynamic therapy (PDT) represents a new localised method of treatment in cancer. The therapeutic effect is mediated by the generation of reactive oxygen species (ROS) and/or the formation of singlet oxygen (1 O2), a process that depends on the photosensitizing agent's interactions with light and oxygen. The photophysical and DNA binding properties of a cationic water-soluble organic derivate of dppz, has previously been reported and its suitability for PDT has been suggested.
dc.format	1 volume
dc.language.iso	en
dc.publisher	Trinity College (Dublin, Ireland). School of Biochemistry and Immunology
dc.relation.isversionof	http://stella.catalogue.tcd.ie/iii/encore/record/C__Rb15647913
dc.subject	Biochemistry & Immunology, Ph.D.
dc.subject	Ph.D. Trinity College Dublin.
dc.title	Ruthenium(11) metal complexes for photodynamic therapy (PDT) or as imaging agents
dc.type	thesis
dc.type.supercollection	thesis_dissertations
dc.type.supercollection	refereed_publications
dc.type.qualificationlevel	Doctoral
dc.type.qualificationname	Doctor of Philosophy (Ph.D.)
dc.rights.ecaccessrights	openAccess
dc.format.extentpagination	pp 314
dc.description.note	TARA (Trinity’s Access to Research Archive) has a robust takedown policy. Please contact us if you have any concerns: rssadmin@tcd.ie